Multivitamin: Clinical Trials

9 trials of Multivitamin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 9 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 4, Terminated 2, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 12Completed 1, Unknown 1
Phase 31Completed 1

Follow Multivitamin: new trials by email Literature Review of Multivitamin trials Research Report on Multivitamin

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PFAS Clinical Trial
Cholestyramine, Centrum - Environmental Exposure
Phase 2Not yet recruitingEmory University3002026-11-012026-09-23
Monitoring, Detoxifying, and Rebalancing Metals During Acute Myeloid Leukemia (AML) Therapy, a Phase 2 Randomized Study
DMSA, Ca-EDTA, Magnesium Sulfate - Acute Myeloid Leukemia (AML)
Phase 2RecruitingM.D. Anderson Cancer Center1402025-05-082026-10-06
Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section
Pregabalin 150mg, multivitamin - Anxiety State, Sedation
Phase 1 / Phase 2UnknownZagazig University742020-11-152021-02-04
IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3
Cyclophosphamide, Indomethacin, IRX-2 - Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion
Phase 2TerminatedUniversity of Southern California102017-11-082025-04-13
A Study to Evaluate the Effect of a Study Product on Quality of Life and Mood
Eurycomalongifoliawater extract (Physta®), Placebo, Multivitamin - Quality of Life, Mood
Phase 2CompletedKGK Science Inc.862014-07-012019-02-27
Cholecalciferol Supplementation in Strengthening Inspiratory Muscles in Cholecalciferol-Deficient Patients With Chronic Obstructive Pulmonary Disease
Cholecalciferol, Laboratory Biomarker Analysis, Multivitamin - Chronic Obstructive Pulmonary Disease, Muscle Weakness
Phase 2TerminatedRoswell Park Cancer Institute42014-04-162017-02-15
Kuvan in People With Schizophrenia and Schizoaffective Disorder
Kuvan, Multivitamin - Schizophrenia, Schizoaffective Disorder
Phase 1 / Phase 2CompletedNew York State Psychiatric Institute272012-10-012017-09-13
Calcitriol, Physical Activity, and Bone Health in Cancer Survivors
Calcitriol, Exercise, Multivitamin - Breast Neoplasms, Bone and Bones
Phase 2CompletedUniversity of Rochester412008-12-012019-04-23
Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
High Dose Multivitamin, Low Dose Multivitamin - Chronic Kidney Disease, Cardiovascular Disease
Phase 2 / Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)41102002-05-012017-10-18

Conditions studied

Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Cardiovascular Diseases (1)  ·  Death (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Muscle Weakness (1)  ·  Psychotic Disorders (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Renal Insufficiency, Chronic (1)  ·  Schizophrenia (1)  ·  Smoking Cessation (1)  ·  Uterine Cervical Dysplasia (1)

Sponsors

Emory University (1)  ·  KGK Science Inc. (1)  ·  M.D. Anderson Cancer Center (1)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)  ·  New York State Psychiatric Institute (1)  ·  Roswell Park Cancer Institute (1)  ·  University of Rochester (1)  ·  University of Southern California (1)  ·  Zagazig University (1)

Countries

United States (7)  ·  Brazil (1)  ·  Canada (1)  ·  Egypt (1)

Top investigators

Andrew Levey, M.D. (1)  ·  Jeffrey A Lieberman, M.D. (1)  ·  Luke J Peppone, Ph.D. (1)  ·  Lynda Roman, MD (1)  ·  Maro Ohanian, DO (1)  ·  Martin Mahoney (1)  ·  Myra A Carpenter, PhD (1)  ·  Sara Abdel Naby, M.D (1)  ·  Stephanie Eick, PhD (1)  ·  TengkuShahrirTengku Adnan (1)

Results publications

PMID 19022547, PMID 21482964, PMID 28943384, PMID 29760559, PMID 30574050, PMID 30629045

NIH funding

P30CA014089 (1), P30CA016056 (1), P50CA090440 (1), U01DK061700 (1)